Genetic Signatures Ltd (GSS) — Cash Flow Quality Index

Latest as of December 2021: 1.68x

Genetic Signatures Ltd (GSS) has a Cash Flow Quality Index of 1.68x as of December 2021. Operating cash flow of AU$7.88 Million exceeds net income of AU$4.70 Million, indicating high earnings quality where cash backs reported profits. Explore cash efficiency ratio of Genetic Signatures Ltd to assess how effectively this company generates cash.

Cash Flow Quality Index

1.68x
Operating CF / Net Income

Operating Cash Flow

AU$7.88 Million
AUD

Net Income

AU$4.70 Million
AUD

Data as of

Dec 2021
Most recent filing

Genetic Signatures Ltd Cash Flow Quality Index (2021–2022)

Historical Cash Flow Quality Index for Genetic Signatures Ltd across 2 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check GSS capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.

Annual Cash Flow Quality Index for Genetic Signatures Ltd (2021–2022)

Year-by-year earnings quality comparison for Genetic Signatures Ltd. For live market cap and the full company financial profile, see Genetic Signatures Ltd market capitalisation.

Year Quality Index Operating CF (AUD) Net Income YoY Change
2022 3.20x AU$9.81 Million AU$3.06 Million ▲ +34.0%
2021 2.39x AU$4.20 Million AU$1.76 Million
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.